Defunct Company
Total Trials
33
As Lead Sponsor
23
As Collaborator
10
Total Enrollment
8,975
NCT00657007
Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 28, 2002
Completion: Mar 31, 2003
NCT00071487
Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE)
Phase: Phase 2
Start: Oct 31, 2003
Completion: Jun 30, 2006
NCT00071812
A Safety and Efficacy Study of LymphoStat-B™ (Monoclonal Anti-BLyS Antibody) in Subjects With Rheumatoid Arthritis (RA)
Start: Dec 31, 2003
Completion: Dec 31, 2005
NCT00094848
Study of TRM-1 (TRAIL-R1 Monoclonal Antibody) in Subjects With Relapsed or Refractory Non-Hodgkin's Lymphoma (NHL)
Start: Jun 30, 2004
Completion: May 31, 2007
NCT00097435
A Study of Albuferon With Ribavirin in Interferon Treatment Experienced Subjects With Chronic Hepatitis C
Start: Oct 31, 2004
Completion: Aug 31, 2007
NCT00583557
A Continuation Trial for Subjects With Rheumatoid Arthritis That Have Completed Protocol LBRA01
Start: Jan 31, 2005
Completion: Nov 30, 2009
NCT00114699
Safety and Efficacy of an Antibody to CCR5 in Individuals With HIV Who Are Not Currently on Antiretroviral Therapy
Start: Apr 30, 2005
Completion: Apr 30, 2006
NCT00115908
A Study of Albuferon and Ribavirin in Interferon Naive Subjects With Chronic Hepatitis C Genotype 1
Start: May 31, 2005
NCT00656006
A Study of Albuferon With Ribavirin in Interferon Alfa Naive Subjects With Chronic Hepatitis C Genotype 2 or 3
Start: Nov 30, 2005
Completion: Apr 30, 2007
NCT00315757
Study of Mapatumumab in Combination With Bortezomib (Velcade) and Bortezomib Alone in Subjects With Relapsed or Refractory Multiple Myeloma
Start: May 31, 2006
Completion: Oct 31, 2010
NCT00402428
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
Phase: Phase 3
Start: Dec 31, 2006
Completion: Feb 28, 2009
NCT00410384
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus
Completion: Mar 31, 2010
NCT00583830
A Study of Mapatumumab in Combination With Paclitaxel and Carboplatin in Subjects With Non-small Cell Lung Cancer
Start: Jan 31, 2007
Completion: Feb 28, 2011
NCT00411385
Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
Start: Feb 28, 2007
Completion: Oct 31, 2008
NCT00424476
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)
Start: May 31, 2007
NCT02016963
An Open-label, Nonrandomized Study to Evaluate the Safety and Immunogenicity of Raxibacumab With Reinjection
Phase: Phase 2/3
Start: Jan 31, 2008
Completion: May 31, 2008
NCT00639678
A Study to Evaluate the Safety and Tolerability of Raxibacumab in Healthy Subjects
Start: Mar 31, 2008
Completion: Sep 30, 2008
NCT00708006
A Study of HGS1029 (AEG40826-2HCl) in Subjects With Advanced Solid Tumors
Start: May 31, 2008
Completion: Jan 31, 2012
NCT00732940
Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE)
Start: Oct 31, 2008
Completion: Mar 31, 2012
NCT00759200
Safety and Efficacy of Albumin Interferon Administered Every 4 Weeks in Genotype 2/3 Hepatitis C Patients
Role: Collaborator
Completion: Dec 31, 2010
NCT00964665
Pharmacokinetic/Pharmacodynamic of Albinterferon Alfa-2b in Chronic Hepatitis B, eAg+, Infection Subjects
Phase: Phase 1/2
Start: Jul 31, 2009
Completion: Not specified
NCT01914770
Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76
Phase: N/A
Completion: Nov 30, 2010
NCT01013818
A Study of HGS1029 in Subjects With Relapsed or Refractory Lymphoid Malignancies
Start: Oct 31, 2009
Completion: Oct 31, 2011
NCT01142011
A Study of Belimumab in Treating Symptomatic Waldenstroms Macroglobulinaemia
Start: Nov 30, 2009
Completion: Jan 31, 2013
NCT01025193
Desensitization With Belimumab in Sensitized Patients Awaiting Kidney Transplant
Start: Feb 28, 2010
Completion: Nov 30, 2011
NCT01088347
Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer
Start: Mar 31, 2010
Completion: Mar 31, 2014
NCT01160666
Efficacy and Safety of Belimumab in Subjects With Primary Sjögren's Syndrome
Completion: Jun 30, 2012
NCT01583530
Study of Belimumab Administered Subcutaneously to Healthy Subjects
Start: Feb 28, 2011
Completion: Sep 30, 2011
NCT01345253
GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia
Start: May 23, 2011
Completion: Sep 21, 2018
NCT01434576
Study to Evaluate the Pharmacodynamics and Safety of HGS1025 in Patients With Ulcerative Colitis
Start: Dec 31, 2011
NCT01597622
BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115
Start: Jun 11, 2012
Completion: Sep 13, 2018
NCT01670565
Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Start: Aug 31, 2012
Completion: Feb 29, 2016